The 3rd Edition of the Drug Safety Symposium - Dubai, hosted by Eminence Group, is a distinguished platform bringing together global experts to address the critical advancements in pharmacovigilance, regulatory compliance, and quality assurance. Taking place at the Holiday Inn & Suites Dubai Science Park, the event aims to foster meaningful discussions on signal detection, adverse event reporting, and AI-driven pharmacovigilance practices. Key topics include global regulatory frameworks, emerging technologies in drug safety, and strategies for ensuring patient safety through quality management systems.
This year’s symposium features an exceptional lineup of speakers, including industry leaders from organizations such as AbbVie, Novartis, Takeda, and Organon. Sessions will cover practical case studies, hands-on workshops on risk management, and panel discussions on navigating complex regulatory landscapes. Notable presentations include insights into FDA and EMA regulations, digital health integration, and innovations like real-world evidence and machine learning in pharmacovigilance.
Beyond its educational offerings, the symposium provides unparalleled networking opportunities, connecting attendees with regulatory authorities, clinical professionals, and industry pioneers. Whether exploring the latest trends in pharmacovigilance or seeking solutions to operational challenges, the Drug Safety Symposium is an unmissable event for professionals committed to advancing excellence in pharmaceutical vigilance and quality assurance.